Centro Médico Teknon
Thyroid cancer treatment cost in Spain depends on the disease stage and required technology, with a diagnostic PET/CT scan typically ranging from $1,300 to $1,800. Surgical options like a thyroidectomy range from $7,000 to $9,000, while radioiodine therapy runs from $2,200 to $3,800. Total expenses vary by clinic tier and the use of robotic systems, often providing 30-50% savings compared to the US. Top treatment centers are located in Barcelona, Madrid, and Pamplona.
Typical Thyroid Cancer Treatment Costs in Spain
Bookimed Expert Insight: For complex cases, choosing a multidisciplinary team is vital for success. Dr. Jose Maria Raventos at Centro Médico Teknon offers 49 years of expertise in complex thyroid surgery. Patients seeking advanced technology find robotic surgery and PET-CT integration at JCI-accredited centers in Barcelona. Quirónsalud Madrid provides a cost-effective alternative by offering free treatment via clinical trials for qualifying oncology patients. Pediatric cases are best served at SJD Barcelona Children's Hospital, a top-3 European specialist center.
| Turcja | Austria | Hiszpania | |
| Tyreoidektomia | od $4,682 | od $9,000 | od $7,046 |
| Terapia protonowa w raku prostaty | od $30,000 | od $80,000 | od $70,000 |
| Terapia protonowa przy raku piersi | od $30,000 | od $55,000 | od $85,000 |
| Terapia protonowa | od $70,000 | od $80,000 | od $25,836 |
| Terapia jodem radioaktywnym przy raku tarczycy | od $1,800 | od $4,500 | od $4,000 |
Dr Jaume Capdevila jest wiodącym badaczem w dziedzinie terapii celowanej raka tarczycy, z dorobkiem ponad 1100 zabiegów przeprowadzonych w Centro Médico Teknon.
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.
Dr Raventos przeprowadził ponad 1100 operacji raka tarczycy w ciągu swojej 49-letniej kariery. Kieruje oddziałem chirurgii małoinwazyjnej w Centro Médico Teknon.
Dr Joseba Rebollo Liceaga posiada ponad 30-letnie doświadczenie w dziedzinie onkologii. Specjalizuje się w leczeniu raka tarczycy w szpitalu Quironsalud Torrevieja.